Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Mar 22;170(2):405–414. doi: 10.1007/s10549-018-4761-7

Table 1.

Characteristics of incident invasive breast cancer cases who survived 12 or more months (Subcohort – 15% sample of all eligible cases).

Characteristica Subcohort (15% sample weight 6.67) N=771 Cases (Breast Cancer Deaths) N=449
N % N %
Age Group
 <40 49 7.1 53 11.8
 40–49 166 23.9 132 29.4
 50–59 249 35.8 159 35.4
 60–69 231 33.2 105 23.4
Ethnicity
 Hispanic 176 25.3 156 34.7
 Non-Hispanic 519 74.7 293 65.3
Year of Diagnosis
 1997–2000 206 29.6 190 42.3
 2001–2004 197 28.3 144 32.1
 2005–2009 292 42.0 115 25.6
Tumor Sizeb
 ≤ 1.0 cm 160 24.5 27 6.4
 >1–3 cm 356 54.6 204 48.5
 >3–5 cm 72 11.1 85 20.1
 >5 cm 32 4.9 40 9.5
 Chest wall/Skin 32 4.9 65 15.4
 Missing 42 28
Number of Positive Nodes
 0 454 66.6 151 34.6
 1–3 159 23.4 165 37.8
 ≥4 68 10.0 121 27.6
 Missing 14 12
Tumor Grade
 Grade I 182 28.1 37 8.9
 Grade II 257 39.7 129 31.0
 Grade III/IV 208 32.1 250 60.1
 Missing 48 33
Estrogen Receptor
 Positive 553 82.4 297 68.6
 Negative 118 17.6 136 31.4
 Missing 24 16
Progesterone Receptor
 Positive 469 72.8 226 54.3
 Negative 175 27.2 190 45.7
 missing 51 33
Her2/neu
 Positive 94 16.6 53 23.8
 Negative 471 83.3 170 76.2
 missing 130 38
a

Tumor characteristics, including estrogen receptor positivity, are influenced by the study restriction to stages I–III and a minimum of 12 months survival.

b

Tumor size categorized to facilitate assessment according to National Comprehensive Cancer Network cut points (Figure 2). Note that most women with missing values had American Joint Commission on Cancer (AJCC) tumor size = T2 (2–5 cm) but actual size unknown; thus, they could not be assigned to the ≤ 3 cm or > 3 cm categories.